Naoero vs Northern Mariana Islands: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Naoero
0.6%
in 2024
Northern Mariana Islands
0.6%
in 2024
Naoero rank
60th
Northern Mariana Islands rank
60th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Naoero
- Northern Mariana Islands
How they compare
Naoero currently reports 0.6% against 0.6% in Northern Mariana Islands, a difference of 0.0%.
Across all 10 years both countries report, Northern Mariana Islands has been ahead every year.
Naoero ranks 60th and Northern Mariana Islands ranks 60th of 246 countries.
Head to head by decade
| Decade | Naoero | Northern Mariana Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.2% | 1.2% | 0.0% | — |
| 2020s | 0.7% | 0.7% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Naoero or Northern Mariana Islands?
- Naoero, at 0.6% against 0.6% in Northern Mariana Islands as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Naoero and Northern Mariana Islands?
- 0.0%, with Naoero ahead.
- How many years of comparable data are there for Naoero and Northern Mariana Islands?
- 10 years are reported by both, from 2015 to 2024.
- How do Naoero and Northern Mariana Islands rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Naoero ranks 60th and Northern Mariana Islands ranks 60th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.